Document is current
Any future updates will be listed below
-
Authors
Correia‐Melo, Clara
Marques, Francisco DM
Anderson, Rhys
Hewitt, Graeme
Hewitt, Rachael
Cole, John
Carroll, Bernadette M
Miwa, Satomi
Birch, Jodie
Merz, Alina
Rushton, Michael D
Charles, Michelle
Jurk, Diana
Tait, Stephen WG
Czapiewski, Rafal
Greaves, Laura
Nelson, Glyn
Bohlooly‐Y, Mohammad
Rodriguez‐Cuenca, Sergio
Vidal‐Puig, Antonio
Mann, Derek
Saretzki, Gabriele
Quarato, Giovanni
Green, Douglas R
Adams, Peter D
von Zglinicki, Thomas
Korolchuk, Viktor I
Passos, João F
-
Funding
Funding for this research was provided by:
FP7‐MITIN (HEALTH‐F4‐2008‐223450)
Medical Research Council Centre for Obesity and Related Metabolic Diseases
BBSRC (BB/I020748/1)
BBSRC (BB/K019260/1)
BBSRC (BB/H022384/1)
BBSRC (BB/K017314/1)
Royal Society University Fellowship
Foundation for Science and Technology (FCT), Portugal
GABBA Program
University of Porto
Newcastle University
David Phillips Fellowship
AstraZeneca
- License Information
-
More Information
Article History
Received: 19 August 2015
Revised: 9 January 2016
Accepted: 12 January 2016
First Online: 4 February 2016
Conflict of interest
: Generation of PGC‐1β −/− mice was funded by AstraZeneca, the employer of Dr. Mohammad Bohlooly‐Y. The other authors declare that they have no conflict of interest.
